Page last updated: 2024-10-18

dalteparin and Arrhythmia

dalteparin has been researched along with Arrhythmia in 4 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Unfractionated heparin (UFH) has been considered the standard anticoagulant for patients with non-ST-segment-elevation acute coronary syndromes (NSTE ACS), yet it has limitations, including an unpredictable dose-response and intravenous administration."1.33Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome: insights from the INTERACT trial. ( Goodman, S, 2005)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wolf, G1
Stahl, RA1
Cano, O1
Osca, J1
Sancho-Tello, MJ1
Olagüe, J1
Castro, JE1
Salvador, A1
Goodman, S1
Ruff, CT1
Wiviott, SD1
Morrow, DA1
Mohanavelu, S1
Murphy, SA1
Antman, EM1
Braunwald, E1

Other Studies

4 other studies available for dalteparin and Arrhythmia

ArticleYear
A woman with increasing weakness of the legs and irregular heartbeat who took her husband's medication.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2002, Volume: 17, Issue:9

    Topics: Aged; Anticoagulants; Arrhythmias, Cardiac; Electrocardiography; Female; Humans; Male; Muscle Weakne

2002
Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices.
    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011, Volume: 13, Issue:3

    Topics: Aged; Aged, 80 and over; Anticoagulants; Arrhythmias, Cardiac; Aspirin; Cardiac Resynchronization Th

2011
Enoxaparin and glycoprotein IIb/IIIa inhibition in non-ST-elevation acute coronary syndrome: insights from the INTERACT trial.
    American heart journal, 2005, Volume: 149, Issue:4 Suppl

    Topics: Acute Disease; Anticoagulants; Arrhythmias, Cardiac; Enoxaparin; Eptifibatide; Heparin; Humans; Myoc

2005
TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction.
    The American journal of medicine, 2007, Volume: 120, Issue:11

    Topics: Adult; Aged; Arrhythmias, Cardiac; Cause of Death; Enoxaparin; Fibrinolytic Agents; Hemorrhage; Hepa

2007